Effects of phenoxybenzamine and prostigmine relative voiding resistance in patients with benign prostatic hypertrophy.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000367:Age Factors; D000368:Aged; D006801:Humans; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology*; D011470:Prostatic Hyperplasia / Q000503:physiopathology*; D014554:Urination / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D010643:Phenoxybenzamine; D009388:Neostigmine